iCoreConnect Inc. (NASDAQ:ICCT) Short Interest Down 61.6% in December

iCoreConnect Inc. (NASDAQ:ICCT) was the recipient of a significant decline in short interest in December. As of December 31st, there was short interest totalling 42,400 shares, a decline of 61.6% from the December 15th total of 110,400 shares. Approximately 5.1% of the company’s shares are sold short. Based on an average daily trading volume, of 409,600 shares, the short-interest ratio is presently 0.1 days.

iCoreConnect Stock Down 3.8 %

Shares of NASDAQ:ICCT opened at $2.27 on Tuesday. The company has a market capitalization of $2.76 million, a price-to-earnings ratio of -0.72 and a beta of 0.84. The company has a 50 day moving average of $3.16 and a two-hundred day moving average of $7.98. iCoreConnect has a 52-week low of $2.27 and a 52-week high of $37.40. The company has a quick ratio of 0.11, a current ratio of 0.11 and a debt-to-equity ratio of 7.93.

Insider Buying and Selling at iCoreConnect

In related news, CEO Robert P. Mcdermott bought 11,839 shares of the company’s stock in a transaction that occurred on Monday, November 25th. The shares were acquired at an average cost of $3.60 per share, for a total transaction of $42,620.40. Following the acquisition, the chief executive officer now owns 61,494 shares in the company, valued at $221,378.40. This represents a 23.84 % increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this link. 59.42% of the stock is currently owned by corporate insiders.

About iCoreConnect

iCoreConnect Inc, a cloud-based software and technology company, provides Health Insurance Portability and Accountability Act (HIPAA) compliant cloud-based software as a service (SaaS) in the United States. The company’s products include iCoreRx, a HIPAA compliant electronic prescription software; iCorePDMP, a solution that checks the patient’s Prescription Drug Monitoring Program (PDMP) history before prescribing controlled substances; iCoreVerify and iCoreVerify+, a HIPAA compliant SaaS solution that automatically retrieves a patients insurance eligibility breakdown to verify their benefits in advance of their appointment and on-demand; iCoreHuddle and iCoreHuddle+, a tool to instantly reveal the revenue potential of each patient; and iCoreCodeGenius, a medical coding reference SaaS solution.